Deprescribing in Older Adults: Is Evidence for Continued Medication Use Generalizable Beyond Age 75?
Older adults over the age of 75 are severely underrepresented in many of the clinical trials used to justify the continued use of medications for chronic disease prevention in advanced age. The gaps in evidence in this population have fueled an interest in research to better understand the potential...
Gespeichert in:
| Veröffentlicht in: | Innovation in aging 2020-12, Vol.4 (Supplement_1), p.802-803 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!